✦ LIBER ✦

Serum EGFR and Serum HER-2/neu Are Useful Predictive and Prognostic Markers in Metastatic Breast Cancer Patients Treated With Metronomic Chemotherapy

✍ Scribed by Cristofanilli, M.

Book ID: 123335898
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 76 KB
Volume: 19
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(08)80120-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum EGFR and serum HER-2/neu are usefu

Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy

✍ Maria Teresa Sandri; Harriet Ann Johansson; Laura Zorzino; Michela Salvatici; Ri 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract ## BACKGROUND. Metronomic chemotherapy has been demonstrated to be of value in patients with advanced breast cancer. No reliable markers of response are available. In breast tumor, HER‐2/__neu__ is a prognostic factor, whereas no definite data exist for EGFR. The aim of the study was t

Prognostic and Predictive Impact of the

Prognostic and Predictive Impact of the HER-2/neuExtracellular Domain (ECD) in the Serum of Patients Treated with Chemotherapy for Metastatic Breast Cancer

✍ Volkmar Müller; Isabell Witzel; Hans Joachim Lück; Günter Köhler; Gunther von Mi 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 240 KB

444 Predictive outcome assessment and mo

444 Predictive outcome assessment and monitoring by serum testing for HER-2/neu, EGFR, uPA and CA 27.29 in metastatic breast cancer

✍ D. Lüftner; P. Henschke; R. Geppert; W. Carney; K.D. Wernecke; K. Possinger 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Serum HER-2/neu and relative resistance

Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer

✍ Suhail M. Ali; Walter P. Carney; Francisco J. Esteva; Monica Fornier; Lyndsay Ha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 2 views

Her-2/neuas Predictive Marker for Endocr

Her-2/neuas Predictive Marker for Endocrine Therapy and Chemotherapy in Patients with Metastatic Breast Cancer

✍ Wolfgang J. Köstler; Christoph C. Zielinski 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 115 KB

Clinical utility of serum HER2/neu in mo

Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies

✍ Francisco J Esteva, Carol D Cheli, Herbert Fritsche… 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 195 KB